Founded with a mission to enhance surgical precision, Alume Biosciences focuses on developing proprietary nerve illumination technology. This innovative technology aims to assist surgeons in identifying and preserving nerves during operations, thereby reducing the risk of nerve damage and associated complications such as incontinence and erectile dysfunction in prostate surgeries, and facial nerve damage in head and neck surgeries. The company is dedicated to making this technology widely available to improve patient outcomes globally.
Dr. Quyen Nguyen, a prominent surgeon-scientist, is a key figure affiliated with Alume Biosciences. The company has garnered attention for its groundbreaking approach to surgical care, attracting investors interested in advancing medical technology. Alume Biosciences' nerve illumination technology has the potential to significantly impact the field of surgery by reducing postoperative complications and improving the quality of life for patients worldwide.
